AstraZeneca scores twin drug approvals alongside vaccine progress
Britain's AstraZeneca has clinched expanded regulatory backing for two medications, including one for blockbuster cancer treatment Lynparza, in a development pipeline that now includes a possible coronavirus vaccine.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
More News: AstraZeneca | Cancer | Cancer & Oncology | Cancer Vaccines | Coronavirus | COVID-19 | Health | UK Health | Vaccines